Folic acid works by serving as the raw material for a family of coenzymes that carry and donate single carbon units throughout the body. These one-carbon transfers are essential for making DNA, producing red blood cells, regulating gene expression through methylation, and maintaining the amino acid balance that keeps tissues healthy. Because folic acid is a synthetic, oxidized form of folate not found in fresh foods, your body must first convert it into an active molecule called tetrahydrofolate before any of this can happen, and that conversion step shapes much of what makes folic acid biochemically interesting.
From Tablet to Active Coenzyme
Folic acid, the form found in supplements and fortified foods, is not biologically active on its own. It is a fully oxidized molecule that needs to be reduced twice before it can participate in the reactions your cells depend on. An enzyme called dihydrofolate reductase (DHFR) handles both reduction steps, first converting folic acid to dihydrofolate and then to tetrahydrofolate (THF), the form that actually does work inside cells.1PubMed Central. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake DHFR also recycles dihydrofolate that gets generated during DNA synthesis back into tetrahydrofolate, keeping the supply of active coenzymes topped up.2Drug Metabolism and Disposition. Characterization and Comparative Studies of Zebrafish and Human Recombinant Dihydrofolate Reductases—Inhibition by Folic Acid and Polyphenols
This conversion step is worth understanding because it is surprisingly slow in humans. Research on human liver tissue found that DHFR activity varies widely between individuals and operates at a much lower rate than in other species.3PubMed Central. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake This means that when you take a large dose of folic acid, some of it can enter circulation in its unmetabolized form. Whether unmetabolized folic acid in the blood causes harm is still debated, but the bottleneck at DHFR is the reason natural food folates, which enter the body already partially reduced, skip this step and move more quickly into active metabolism.
How Folate Gets Into Your Cells
Before folate coenzymes can do anything useful, they have to cross cell membranes. Your body relies on at least two major specialized transporters to accomplish this. The proton-coupled folate transporter (PCFT) handles absorption in the small intestine, where the slightly acidic environment near the intestinal wall helps drive folate uptake. Once folate is in the bloodstream, a different transporter called the reduced folate carrier (RFC) takes over. RFC is found on the surface of cells throughout the body and is the main route by which most tissues pull in the folate they need.4PubMed Central. Biology of the major facilitative folate transporters SLC19A1 and SLC46A1
A rare genetic condition called hereditary folate malabsorption illustrates how critical PCFT is. People born with mutations in the gene encoding PCFT cannot absorb folate from their diet at all, leading to severe deficiency in infancy.5PubMed Central. Mechanisms of membrane transport of folates into cells and across epithelia There are also folate receptors, membrane-bound proteins with very high affinity for folate, that play roles in specific tissues like the kidneys and the placenta. The presence of multiple transport systems underscores how important steady folate delivery is to the body.
Building the Letters of DNA
The most famous job of folate coenzymes is in DNA synthesis, and this is where the “one-carbon transfer” concept becomes concrete. DNA is built from four nucleotide building blocks, and folate is required to make two of the four categories: pyrimidines (specifically thymidylate) and purines.
To make thymidylate, the nucleotide abbreviated dTMP, a folate coenzyme called 5,10-methylenetetrahydrofolate donates a one-carbon unit directly to a precursor molecule. This reaction is the reason folate deficiency stalls DNA replication: without enough thymidylate, cells cannot copy their genomes properly. The enzyme that catalyzes this step also oxidizes the folate coenzyme to dihydrofolate, which then needs to be recycled back to THF by DHFR. This is the cycle that keeps the whole system running.
Purine synthesis depends on a different folate form. Two separate steps in the construction of the purine ring require 10-formyltetrahydrofolate, which donates carbon atoms that become part of the ring’s final structure.6PubMed Central. Folate-Dependent Purine Nucleotide Biosynthesis in Humans Purines are the A and G bases of DNA and RNA, so any shortfall in their production affects every dividing cell in the body. Research on folate-deficient red blood cell precursors found that restoring purine supply was just as critical as restoring thymidylate for reversing the defects of megaloblastic anemia, the hallmark blood disorder of folate deficiency.7PubMed. Apoptosis in megaloblastic anemia occurs during DNA synthesis by a p53-independent, nucleoside-reversible mechanism
The Methylation Cycle and Gene Regulation
Beyond DNA synthesis, folate coenzymes power a second major pathway: the methylation cycle. Here, 5-methyltetrahydrofolate donates its one-carbon unit to an enzyme called methionine synthase, which uses it to convert the amino acid homocysteine into methionine. This reaction requires vitamin B12 as a cofactor. The methionine produced is then converted into S-adenosylmethionine (SAM), which is the body’s principal methyl donor.8PubMed. Vitamin B(12) , folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation
SAM’s methyl groups are used in hundreds of reactions. They silence or activate genes by methylating DNA. They modify proteins and lipids. They help produce neurotransmitters, creatine, and the phospholipids that make up cell membranes. Disruptions to methionine synthase, whether from folate deficiency or B12 deficiency, ripple out to affect all of these methylation-dependent processes.9PubMed. Vitamin B(12) , folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation This is why folate status can influence gene expression patterns, and why researchers study the link between folate intake and epigenetic changes across the lifespan.
Why Folate Is Critical During Neural Tube Closure
The best-known public health application of folic acid is preventing neural tube defects (NTDs), which include conditions like spina bifida and anencephaly. The neural tube closes within the first few weeks of pregnancy, often before a woman knows she is pregnant, and the cells lining this tube are among the most rapidly dividing in the embryo.
Research has shown that folic acid supplementation restores normal cell proliferation in the developing neuroepithelium. In mouse models carrying a mutation that causes cranial NTDs, supplemental folic acid sped up the transition of cells from the DNA-copying phase to the next stage of cell division, specifically in the affected region of the neural tube.10PubMed Central. Cellular mechanisms underlying Pax3-related neural tube defects and their prevention by folic acid The interpretation is that folic acid compensates for the genetic defect by pushing cell-cycle progression hard enough that the neural folds can meet and fuse in time.
A complementary hypothesis focuses on the sheer demand for nucleic acid building blocks. Neuroepithelial cells express high levels of the glycine cleavage system, an enzyme complex that feeds one-carbon units from glycine into folate metabolism, suggesting these cells are particularly hungry for folate-derived nucleotides.11PubMed. Why is folate effective in preventing neural tube closure defects? When folate supply is inadequate, these cells simply cannot divide fast enough to close the tube on schedule. The practical upshot is unchanged: adequate folate before and during early pregnancy substantially lowers NTD risk, which is why public health agencies worldwide recommend folic acid supplementation for women of childbearing age.
What Goes Wrong in Blood Cell Production
Red blood cells are produced at an extraordinary rate, roughly millions per second, and each new cell requires a full copy of the genome. When folate is scarce, DNA synthesis slows down, but the rest of the cell’s growth machinery keeps running on schedule. The result is megaloblastic anemia: red blood cell precursors grow large but cannot divide properly, and many of them die before maturing. Research has established that both the thymidylate and purine arms of folate-dependent nucleotide synthesis contribute to this defect, meaning it is not just one pathway failing but two simultaneously.12PubMed. Apoptosis in megaloblastic anemia occurs during DNA synthesis by a p53-independent, nucleoside-reversible mechanism
The clinical picture is distinctive: oversized red blood cells, low red cell counts, fatigue, and sometimes neurological symptoms when the deficiency is severe. The same pattern occurs in vitamin B12 deficiency, for reasons tied directly to how the two vitamins share metabolic machinery.
The Methyl Folate Trap and the B12 Connection
Folate and vitamin B12 are deeply entangled, and the concept of the “methyl folate trap” explains why. When B12 is missing, methionine synthase cannot function. This means 5-methyltetrahydrofolate, the form of folate that normally donates its methyl group to homocysteine, has nowhere to unload. It accumulates, and because the reaction that created it is effectively irreversible, it cannot be converted back to the forms of folate needed for DNA synthesis.13PubMed. Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: a case for the methylfolate trap
The result is a functional folate deficiency even when total folate levels in the body appear adequate. Folate is essentially locked in one form and unavailable for making thymidylate or purines. Research using cell models has shown that this “trap” extends into the nucleus, where 5-methyltetrahydrofolate accumulates and suppresses nuclear thymidylate biosynthesis, leading to DNA damage and the same megaloblastic anemia seen in straightforward folate deficiency.14PubMed Central. Folate rescues vitamin B(12) depletion-induced inhibition of nuclear thymidylate biosynthesis and genome instability
An older but influential theory adds a layer to this picture. The cell may “interpret” B12 deficiency as methionine deficiency and respond by shunting folate toward the methylation pathway to conserve methionine for critical reactions in the brain and nervous system. This protective response comes at the cost of DNA synthesis and red blood cell production, which is why B12-deficient patients develop anemia.15PubMed. The methyl folate trap. A physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid induced exacerbation of subacute combined degeneration in pernicious anaemia This is also why giving folic acid to someone with undiagnosed B12 deficiency can be dangerous: the folic acid may temporarily correct the anemia (restoring enough nucleotide synthesis to let blood cells divide again) while the underlying B12 deficiency continues to damage the nervous system, masking the diagnosis.
Effects on Blood Vessels and Nitric Oxide
Folate’s mechanism of action extends beyond DNA and methylation into cardiovascular territory. In endothelial cells, the cells lining blood vessels, folic acid appears to work through DHFR to maintain the supply of a molecule called tetrahydrobiopterin (BH4). BH4 is essential for nitric oxide synthase, the enzyme that produces nitric oxide, the signaling molecule that tells blood vessels to relax and dilate.
When BH4 levels fall, nitric oxide synthase starts producing superoxide radicals instead of nitric oxide, a malfunction sometimes called “uncoupling.” Research in both cell cultures and mice showed that folic acid, by boosting DHFR activity, increased BH4 and nitric oxide while reducing superoxide production. When DHFR was blocked, folic acid lost its protective effect, confirming that the benefit runs specifically through that enzyme.16Journal of Molecular and Cellular Cardiology. Mechanistic Insights into Folic Acid-dependent Vascular Protection: Dihydrofolate reductase-mediated Reduction in Oxidant Stress in Endothelial Cells and Angiotensin II-Infused Mice This mechanism is distinct from folate’s role in lowering homocysteine (high homocysteine is itself associated with vascular damage) and suggests folic acid may protect blood vessels through at least two independent routes.
Folate Inside Mitochondria
Folate metabolism does not happen only in the cell’s main compartment. Mitochondria, the energy-producing organelles, have their own folate pathway that runs somewhat independently. Mitochondrial one-carbon metabolism contributes to the synthesis of nucleotides needed for replicating mitochondrial DNA, influences the expression of genes encoded by that DNA, and helps regulate the cell’s overall redox balance.17PubMed Central. The Roles of Mitochondrial Folate Metabolism in Supporting Mitochondrial DNA Synthesis, Oxidative Phosphorylation, and Cellular Function
This mitochondrial arm of folate metabolism has gained attention in cancer research. Rapidly growing cells, and cells under low-oxygen conditions, appear to depend heavily on mitochondrial one-carbon metabolism to maintain redox balance. Serine, an amino acid, is broken down inside mitochondria in a folate-dependent reaction that generates the reducing equivalents cells need to handle oxidative stress.18PubMed Central. Mitochondrial one-carbon metabolism maintains redox balance during hypoxia This connection between folate, mitochondria, and cellular stress responses is part of the reason folate pathways are increasingly recognized as potential therapeutic targets.
The Cancer Paradox
Folate’s role in cancer is genuinely complicated, and the evidence points in two directions depending on timing. In healthy tissue, adequate folate intake is associated with lower risk of certain cancers, particularly colorectal cancer. The likely explanation follows directly from the mechanisms above: sufficient folate supports accurate DNA synthesis and proper methylation patterns, both of which protect against the mutations and epigenetic disruptions that can initiate cancer.
However, once precancerous or cancerous cells already exist, the same mechanisms can work against you. Cancer cells are dividing rapidly and need DNA building blocks just like any other fast-growing cell. Supplying extra folate may fuel their growth. A review of the evidence on folic acid and colorectal cancer described this as a “dual-modulator effect,” where folate prevents cancer in the absence of malignant foci but may promote tumor growth when such foci are already present.19PubMed Central. The relationship between folic acid and colorectal cancer; a literature review Consistent with this, a large epidemiological study found that higher total folate intake in the distant past was linked to lower colorectal cancer risk, while more recent intake was more strongly linked to lower risk of adenomas (the precancerous polyps that precede most colorectal cancers).20The American Journal of Clinical Nutrition. Folate intake and risk of colorectal cancer and adenoma: modification by time
This dual role is also why antifolate drugs like methotrexate are used in cancer chemotherapy and autoimmune disease treatment. Methotrexate binds to DHFR with extremely high affinity, blocking the recycling of dihydrofolate back to tetrahydrofolate and starving rapidly dividing cells of the nucleotides they need.21PubMed Central. Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics In essence, antifolate chemotherapy weaponizes the same pathway that folic acid supplements are meant to support.
Genetic Variation in Folate Metabolism
Not everyone processes folate the same way. The most studied genetic variant involves the enzyme methylenetetrahydrofolate reductase (MTHFR), which converts 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate, the form used in the methylation cycle. A common variant called C677T produces a less stable version of the enzyme. People who carry two copies of the T variant (homozygous T/T) have reduced MTHFR activity, which can lead to higher homocysteine levels and altered folate distribution among its various active forms.22The Journal of Nutrition. Polymorphisms of Methylenetetrahydrofolate Reductase and Other Enzymes: Metabolic Significance, Risks and Impact on Folate Requirement
For people with this variant, the practical implication is that they may need more folate to maintain normal homocysteine levels and adequate methylation. The MTHFR C677T variant is common, present in roughly 10 to 15 percent of many populations in homozygous form, though the frequency varies by ethnicity. Despite widespread online claims, the variant is not a catastrophic “broken gene” but rather a moderate efficiency reduction that matters most when dietary folate is low. With good folate intake, the functional impact is substantially blunted.
Gut Bacteria as a Folate Source
Your intestinal bacteria can synthesize folate on their own, a trick humans cannot perform because we lack the necessary biosynthetic enzymes. Several common gut bacterial species produce folate in quantities that, at least in theory, could meaningfully contribute to your body’s supply. Some researchers have explored whether these bacteria could be leveraged through probiotics or dietary strategies to boost folate availability in the gut, where local folate concentrations may matter for the health of the intestinal lining itself.23Taylor & Francis Online (Crit Rev Food Sci Nutr). Bacterial folate biosynthesis and colorectal cancer risk: more than just a gut feeling This is still an emerging area of research, but it adds another dimension to folate biology: your body’s folate status is not determined solely by what you eat or supplement, but also by the microbial community living in your gut.
How Skin Pigmentation Connects to Folate
One of the more surprising places folate’s mechanism of action shows up is in evolutionary biology. Ultraviolet radiation breaks down folate in the blood, particularly 5-methyltetrahydrofolate, both through direct photolysis and through reactive oxygen species generated by UVA exposure. This destruction of circulating folate has been proposed as a major selective pressure driving the evolution of dark skin pigmentation in populations living near the equator. Melanin in the skin acts as a natural shield, protecting the folate in your bloodstream from UV degradation.24PubMed Central. Human skin pigmentation as an adaptation to UV radiation The logic runs in the other direction, too: at higher latitudes with less UV, lighter skin evolved to allow enough UV penetration for vitamin D synthesis, since folate destruction was less of a threat in those environments. Whether you find this argument fully convincing or not, the fact that folate degradation by sunlight may have shaped something as visible as human skin color speaks to how fundamental these coenzymes are to reproductive success and survival.